Cargando…
Thymidine kinase 1 through the ages: a comprehensive review
Proliferation markers, such as proliferating cell nuclear antigen (PCNA), Ki-67, and thymidine kinase 1 (TK1), have potential as diagnostic tools and as prognostic factors in assessing cancer treatment and disease progression. TK1 is involved in cellular proliferation through the recovery of the nuc...
Autores principales: | Bitter, Eliza E., Townsend, Michelle H., Erickson, Rachel, Allen, Carolyn, O’Neill, Kim L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694900/ https://www.ncbi.nlm.nih.gov/pubmed/33292474 http://dx.doi.org/10.1186/s13578-020-00493-1 |
Ejemplares similares
-
Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells
por: Velazquez, Edwin J., et al.
Publicado: (2020) -
Thymidine kinase in breast cancer.
por: Robertson, J. F., et al.
Publicado: (1990) -
Thymidine Kinase 1 Upregulation Is an Early Event in Breast Tumor Formation
por: Alegre, Melissa M., et al.
Publicado: (2012) -
Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies
por: Weagel, Evita G., et al.
Publicado: (2018) -
TK1 expression influences pathogenicity by cell cycle progression, cellular migration, and cellular survival in HCC 1806 breast cancer cells
por: Bitter, Eliza E., et al.
Publicado: (2023)